Targeting the D Series Resolvin Receptor System for the Treatment of Osteoarthritis Pain

Arthritis and Rheumatology

Volumn 69, Issue 5, 2017, Pages 996-1008

  Huang, Junting ^a   Burston, James J ^a   Li, Li ^a   Ashraf, Sadaf ^a   Mapp, Paul I ^a   Bennett, Andrew J ^a   Ravipati, Srinivasarao ^a   Pousinis, Petros ^a   Barrett, David A ^a   Scammell, Brigitte E ^a   Chapman, Victoria ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

17(R) HYDROXY DOCOSAHEXAENOIC ACID; ARACHIDONATE 15 LIPOXYGENASE; CHEMOKINE LIKE RECEPTOR 1; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID; MESSENGER RNA; PROTEIN; PROTEIN ALX; RESOLVIN D2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; 17-HYDROXY-4,7,10,13,15,19-DOCOSAHEXAENOIC ACID; CHEMOKINE RECEPTOR; CMKLR1 PROTEIN, HUMAN; CMKLR1 PROTEIN, RAT; ENZYME INHIBITOR; HSH2D PROTEIN, HUMAN; IODOACETIC ACID; LIPOXIN A(4) RECEPTOR, RAT; LIPOXIN RECEPTOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRALGIA; ARTICLE; ASTROCYTOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; LIPID BLOOD LEVEL; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; MEDIAL TIBIAL PLATEAU; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; REPLACEMENT ARTHROPLASTY; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL BEHAVIOR; ARTICULAR CARTILAGE; CHEMICALLY INDUCED; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; GLIA; KNEE MENISCUS; KNEE OSTEOARTHRITIS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD; SURGERY; SYNOVIUM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ARTHRALGIA; BEHAVIOR, ANIMAL; CARTILAGE, ARTICULAR; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; ENZYME INHIBITORS; GENE EXPRESSION; HUMANS; IODOACETIC ACID; MENISCI, TIBIAL; NEUROGLIA; OSTEOARTHRITIS, KNEE; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CHEMOKINE; RECEPTORS, LIPOXIN; RNA, MESSENGER; SPINAL CORD; SYNOVIAL MEMBRANE;

EID: 85018718620     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.40001     Document Type: Article

References (49)

1. Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H, et al. Osteoarthritis. Lancet 2015;386:376–87.
2. Karsdal MA, Bay-Jensen AC, Lories RJ, Abramson S, Spector T, Pastoureau P, et al. The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments? Ann Rheum Dis 2014;73:336–48.
3. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197–223.
4. Felson DT, Chaisson CE, Hill CL, Totterman SM, Gale ME, Skinner KM, et al. The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med 2001;134:541–9.
5. Arendt-Nielsen L, Skou ST, Nielsen TA, Petersen KK. Altered central sensitization and pain modulation in the CNS in chronic joint pain. Curr Osteoporos Rep 2015;13:225–34.
6. Dakin H, Gray A, Fitzpatrick R, Maclennan G, Murray D, the KAT Trial Group. Rationing of total knee replacement: a cost-effectiveness analysis on a large trial data set. BMJ Open 2012;2:e000332.
7. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002;196:1025–37.
8. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000;192:1197–204.
9. Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, et al. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A 2010;107:1660–5.
10. Dalli J, Winkler JW, Colas RA, Arnardottir H, Cheng CY, Chiang N, et al. Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents. Chem Biol 2013;20:188–201.
11. Chiang N, Fredman G, Backhed F, Oh SF, Vickery T, Schmidt BA, et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 2012;484:524–8.
12. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 2005;201:713–22.
13. Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, Serhan CN. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23. J Immunol 2007;178:3912–7.
14. Serhan CN, Petasis NA. Resolvins and protectins in inflammation resolution. Chem Rev 2011;111:5922–43.
15. Ji RR, Xu ZZ, Strichartz G, Serhan CN. Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci 2011;34:599–609.
16. Sungjae Yoo, Lim JY, Hwang SW. Resolvins: endogenously-generated potent painkilling substances and their therapeutic perspectives. Curr Neuropharmacol 2013;11:664–76.
17. Lima-Garcia JF, Dutra RC, da Silva K, Motta EM, Campos MM, Calixto JB. The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats. Br J Pharmacol 2011;164:278–93.
18. Bang S, Yoo S, Yang TJ, Cho H, Kim YG, Hwang SW. Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br J Pharmacol 2010;161:707–20.
19. Bang S, Yoo S, Yang TJ, Cho H, Hwang SW. 17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. Br J Pharmacol 2012;165:683–92.
20. Xu ZZ, Berta T, Ji RR. Resolvin E1 inhibits neuropathic pain and spinal cord microglial activation following peripheral nerve injury. J Neuroimmune Pharmacol 2012;8:37–41.
21. Xu ZZ, Zhang L, Liu T, Park JY, Berta T, Yang R, et al. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med 2010;16:592–7.
22. Abdelmoaty S, Wigerblad G, Bas DB, Codeluppi S, Fernandez-Zafra T, El-Awady el-S, et al. Spinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release. PloS One 2013;8:e75543.
23. Feng QX, Feng F, Feng XY, Li SJ, Wang SQ, Liu ZX, et al. Resolvin D1 reverses chronic pancreatitis-induced mechanical allodynia, phosphorylation of NMDA receptors, and cytokines expression in the thoracic spinal dorsal horn. BMC Gastroenterol 2012;12:148.
24. Tang H, Liu Y, Yan C, Petasis NA, Serhan CN, Gao H. Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury. J Immunol 2014;193:3769–78.
25. Sagar DR, Burston JJ, Hathway GJ, Woodhams SG, Pearson RG, Bennett AJ, et al. The contribution of spinal glial cells to chronic pain behaviour in the monosodium iodoacetate model of osteoarthritic pain. Mol Pain 2011;7:88.
26. Mapp PI, Sagar DR, Ashraf S, Burston JJ, Suri S, Chapman V, et al. Differences in structural and pain phenotypes in the sodium monoiodoacetate and meniscal transection models of osteoarthritis. Osteoarthritis Cartilage 2013;21:1336–45.
27. Sagar DR, Nwosu L, Walsh DA, Chapman V. Dissecting the contribution of knee joint NGF to spinal nociceptive sensitization in a model of OA pain in the rat. Osteoarthritis Cartilage 2015;23:906–13.
28. Erhuma A, Salter AM, Sculley DV, Langley-Evans SC, Bennett A. Prenatal exposure to a low protein diet programmes disordered regulation of lipid metabolism in the ageing rat. Am J Physiol Endocrinol Metab 2007;292:1702–14.
29. Sagar DR, Ashraf S, Xu L, Burston JJ, Menhinick MR, Poulter CL, et al. Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. Ann Rheum Dis 2014;73:1558–65.
30. Shimura Y, Kurosawa H, Sugawara Y, Tsuchiya M, Sawa M, Kaneko H, et al. The factors associated with pain severity in patients with knee osteoarthritis vary according to the radiographic disease severity: a cross-sectional study. Osteoarthritis Cartilage 2013;21:1179–84.
31. Hulejova H, Baresova V, Klezl Z, Polanska M, Adam M, Senolt L. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine 2007;38:151–6.
32. Venn G, Nietfeld JJ, Duits AJ, Brennan FM, Arner E, Covington M, et al. Elevated synovial fluid levels of interleukin-6 and tumor necrosis factor associated with early experimental canine osteoarthritis. Arthritis Rheum 1993;36:819–26.
33. Alvarez-Soria MA, Herrero-Beaumont G, Moreno-Rubio J, Calvo E, Santillana J, Egido J, et al. Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis. Osteoarthritis Cartilage 2008;16:1484–93.
34. Fiore S, Antico G, Aloman M, Sodin-Semrl S. Lipoxin A4 biology in the human synovium: role of the ALX signaling pathways in modulation of inflammatory arthritis. Prostaglandins Leukot Essent Fatty Acids 2005;73:189–96.
35. Guzman RE, Evans MG, Bove S, Morenko B, Kilgore K. Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol 2003;31:619–24.
36. Janusz MJ, Bendele AM, Brown KK, Taiwo YO, Hsieh L, Heitmeyer SA. Induction of osteoarthritis in the rat by surgical tear of the meniscus: inhibition of joint damage by a matrix metalloproteinase inhibitor. Osteoarthritis Cartilage 2002;10:785–91.
37. Beyreuther B, Callizot N, Stohr T. Antinociceptive efficacy of lacosamide in the monosodium iodoacetate rat model for osteoarthritis pain. Arthritis Res Ther 2007;9:R14.
38. Herrera BS, Ohira T, Gao L, Omori K, Yang R, Zhu M, et al. An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption. Br J Pharmacol 2008;155:1214–23.
39. Gao L, Faibish D, Fredman G, Herrera BS, Chiang N, Serhan CN, et al. Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. J Immunol 2013;190:689–94.
40. Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, et al. RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis. FASEB J 2006;20:401–3.
41. Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007;10:1361–8.
42. Moilanen LJ, Hamalainen M, Nummenmaa E, Ilmarinen P, Vuolteenaho K, Nieminen RM, et al. Monosodium iodoacetate-induced inflammation and joint pain are reduced in TRPA1 deficient mice: potential role of TRPA1 in osteoarthritis. Osteoarthritis Cartilage 2015;23:2017–26.
43. Shutov LP, Warwick CA, Shi X, Gnanasekaran A, Shepherd AJ, Mohapatra DP, et al. The complement system component C5a produces thermal hyperalgesia via macrophage-to-nociceptor signaling that requires NGF and TRPV1. J Neurosci 2016;36:5055–70.
44. Gao YJ, Ji RR. Targeting astrocyte signaling for chronic pain. Neurotherapeutics 2010;7:482–93.
45. Ji RR, Berta T, Nedergaard M. Glia and pain: is chronic pain a gliopathy? Pain 2013;154 Suppl 1:S10–28.
46. Cui YH, Le Y, Gong W, Proost P, van Damme J, Murphy WJ, et al. Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. J Immunol 2002;168:434–42.
47. Kong Y, Ruan L, Qian L, Liu X, Le Y. Norepinephrine promotes microglia to uptake and degrade amyloid β peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme. J Neurosci 2010;30:11848–57.
48. Lee Y, Pai M, Brederson JD, Wilcox D, Hsieh G, Jarvis MF, et al. Monosodium iodoacetate-induced joint pain is associated with increased phosphorylation of mitogen activated protein kinases in the rat spinal cord. Mol Pain 2011;7:39.
49. 4 as an anti-inflammatory mediator in the human endometrium. Reproduction 2011;142:345–52.